Children and environmental toxics: special symposium at New Orleans scientific meeting

The latest research on children's health and the environment - a relatively new area of scientific exploration - is the focus of a special three-day symposium here Aug. 22-24 during the national meeting of the American Chemical Society, the world's largest scientific society. Leaders in the field of children's health and risk assessment will discuss how youngsters are exposed to toxics, the difficulty in obtaining and analyzing blood samples from children, and how regulators interpret and use the measurements. Some of the 30 papers that will be presented during the symposium are described below. All papers are embargoed until the time of presentation, unless otherwise noted.

Legislating Children's Health - The question, "When is there enough science to make a decision?" is often critical to legislative and regulatory actions. A science fellow with the House Committee on Agriculture will provide personal insights on the need to integrate science and the decision-making process, and discuss several significant initiatives to do so. (B. Shurdut - Comm. on Agriculture, U.S. House of Representatives, Washington, D.C.; ENVR 6; Sunday, Aug. 22, 8:35 a.m.; Convention Center, Room 209. See page 88 in the final program.)

Measuring Children's Exposure to Environmental Hazards - Children can be exposed to environmental hazards in many ways: breathing polluted air, eating contaminated food, or touching treated surfaces. Two studies in Minnesota measure multipathway exposure to chemicals in the environment. One study examined elementary-school-aged children from low-income, racially diverse, inner-city neighborhoods in Minneapolis, and documented exposure to airborne volatile organic chemicals outdoors, and indoors at school and at home. The other study examined whether diet is the primary exposure pathway for organophosphate pesticides, and compared the exposure of urban and non-urban children. (K. Sexton - University of Minnesota, Minneapolis, Minn.; ENVR

Contact: Charmayne Marsh
American Chemical Society

Page: 1 2 3

Related biology news :

1. Childrens Hospital Boston receives more than $10 million to help make smallpox vaccine safer
2. Childrens eating patterns show striking changes in two decades
3. Childrens Memorial, TGen announce partnership
4. Federal grant supports advances in infant heart disease at Childrens Hospital of Philadelphia
5. Children with HIV more likely to utilize health services than infected adults
6. Packard Childrens Hospital gift creates new biotech research center for childrens health
7. From Hopkins: Children may outgrow peanut allergies
8. Novel gene therapy on the horizon, says Brenner Childrens Hospital pediatrician
9. Childrens Hospital Boston researchers regenerate zebrafish heart muscle
10. Childrens Hospital Boston researchers use therapeutic cloning to create functional tissue in cows
11. Children in lower socio-economic backgrounds at high risk for type-2 diabetes

Post Your Comments:

(Date:8/21/2020)... ... August 18, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage ... Food and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) ... severe COVID-19. Approval of this IND allows Sentien to initiate a Phase 1/2 ...
(Date:8/12/2020)... ... 2020 , ... Both Roche, based in Basel, Switzerland, and ... with Housey Pharma’s HMI subsidiary to gain access to its core-enabling technology for ... Development spending in excess of US $10 billion. , Scientists at Housey Pharma ...
(Date:8/5/2020)... , ... August 05, 2020 , ... Regenative Labs has ... new innovations, CoreText™ and ProText™, making them the first Wharton’s jelly allografts to be ... a syringe. The company’s solutions are the first Wharton’s jelly allograft product to be ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... COLLEGE STATION, Texas (PRWEB) , ... July 29, ... ... pre-qualified cleanroom solutions today announced the launch of its new tagline, “BUILDING FOR ... within the biopharmaceutical industry and around the globe, requiring fast track capacity to ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, Inc. ... of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and ... a strategic partnership whereby Catalent will provide support for the development, manufacturing, and ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... the life sciences industry, today announced the release of its signature product ... Medical Science Liaisons (MSLs) and other field medical professionals. , Beacon ...
(Date:7/18/2020)... ... , ... “We are thrilled to deliver this new technology to the industry” ... kind on the market and we were pleased that the IFT jury recognized that.” ... ingredients, creating a natural way to extend the shelf life and improve the safety ...
Breaking Biology Technology:
Cached News: